Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M.C. Mateos
Observed names:
M. Carmen Mateos,
Maria C. Mateos,
Maria Carmen Mateos,
Maria del Carmen Mateos,
María C. Mateos,
María Carmen Mateos,
María del Carmen Mateos,
Mª Carmen Mateos
show all 8
Institutions:
Complejo Hospitalario de Navarra,
Navarre Institute of Health Research,
Universidad de Navarra
Observed institutions:
Complejo Hospitalario de Navarra,
Navarre Institute of Health Research,
Clinica Universidad de Navarra,
Hospital Virgen del Camino,
Hospital Universitario de León,
Universidad de Navarra
show all 6
OpenAlex ID:
A5109592198
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
2019
·
Carmen Vicente
, Elena Arriazu
, et al.
·
Cancer Letters
·
45
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia
2020
·
Elena Arriazu
, Carmen Vicente
, et al.
·
Blood Cancer Journal
·
36
PDF
Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation
2022
·
Irene Peris
, Silvia Romero-Murillo
, et al.
·
Blood
·
30
Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter’s syndrome) and non‐transformed B‐cell chronic lymphocytic leukaemia in Spain: a report of seven cases
2010
·
Jose‐Manuel Calvo‐Villas
, Jose Antonio Fernández
, et al.
·
British Journal of Haematology
·
14
PDF
Infecciones en pacientes oncohematológicos no trasplantados
2005
·
M.C. Mateos
, J.M. Arguiñano
, et al.
·
Anales del Sistema Sanitario de Navarra
·
10
PDF
NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2
2005
·
Idoya Lahortiga
, Elena Belloni
, et al.
·
Cancer Genetics and Cytogenetics
·
9
Genetic evolution and relapse‐associated mutations in adult T‐cell acute lymphoblastic leukemia patients treated in PETHEMA trials
2025
·
Celia González‐Gil
, Thaysa Lopes
, et al.
·
HemaSphere
·
3
PDF
Minimal Residual Disease Detection By Single Cell DNA Sequencing Technology: A Feasible Approach for Clinical Application and Identification of the Landscape of MRD Clones
2023
·
Ana Alfonso Pierola
, Beñat Ariceta
, et al.
·
Blood
·
3
PDF
Concomitant lymphoplasmacytic lymphoma, multiple myeloma, and amyloidosis: A diagnostic and therapeutic challenge
2022
·
Candela Ceballos
, Cristina Alburquerque
, et al.
·
Clinical Case Reports
·
3
Co-mutation signatures are age-dependent and impact the prognosis in NPM1-mutated acute myeloid leukemia: a PETHEMA multicenter study
2026
·
José Vicente Gil
, Claudia Sargas
, et al.
·
Haematologica
·
2
Incidence, Treatment and Prognosis of Patients with Relapsed Burkitt Lymphoma/Leukemia Treated with Specific Chemotherapy or Immunochemotherapy in Spain
2015
·
Alberto Pineda
, Juan-Manuel Sancho
, et al.
·
Blood
·
2
Prognostic impact of variant allele frequency in intensively treated patients with NPM1 -mutated AML: a PETHEMA study
2026
·
José Vicente Gil
, Claudia Sargas
, et al.
·
Blood
·
1
Stabilization of the PP2A-B56α complex overcomes venetoclax-azacitidine resistance by impairing OXPHOS in AML
2026
·
Silvia Romero-Murillo
, Irene Peris
, et al.
·
JCI Insight
PDF
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group
2026
·
Rafael Colmenares
, Eva Barragán
, et al.
·
Bone Marrow Transplantation
PDF
Multilineage Acute Leukemia During the Treatment of a Patient With Breast Cancer With Docetaxel and Double Anti-her2/neu Blockade: Perspectives and Points to Consider
2021
·
Jorge Illarramendi
, María Carmen Mateos
, et al.
·
Mastology
PDF
Tumor Immune Escape Mediated by Th17ccr4‐ccr6+ Cells and Il‐6/il‐10/il‐17a in Acute Myeloid Leukemia
2019
·
A. Zabalza
, E. Soria
, et al.
·
HemaSphere
Pf239 Combined Targeting of Bcl-2 and Set-pp2a Interaction Induces Potent and Synergistic Anti-leukemic Effects on Acute Myeloid Leukemia
2019
·
I. Peris
, E. Martínez-Balsalobre
, et al.
·
HemaSphere
Determinación de enfermedad mínima residual molecular en sangre periférica mediante NGS como nueva herramienta en el seguimiento posttrasplante alogénico de progenitores hematopoyéticos
2019
·
Eva Bandrés
, Marı́a José Calasanz
, et al.
·
Depósito Académico Digital Universidad de Navarra (University of Navarra)
Intensive Immunochemotherapy In Patients With B-Cell Lymphoma, Unclassifiable (B-UCL), With Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Burkitt Lymphoma (BL): A Comparison With BL Patients Treated With The Same Protocol In The Pethema-Burkimab-04 Trial
2013
·
Pere Barba
, Albert Oriol
, et al.
·
Blood
Intrathecal Liposomal Cytarabine (DepoCyte®) for Treatment of Leptomeningeal Involvement From Transformed (Richter's syndrome) and Non-Transformed B-Cell Chronic Lymphocytic Leukemia (B-CLL) in Spain: Report of 8 Cases.
2009
·
Jose Manuel Calvo-Villas
, Jose Antonio Fernández
, et al.
·
Blood
Show more works
View as search
Works count:
20
Citation count:
158
H-index:
6
I10-index:
5
Year
Topic
Type